Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain
This study has been completed.
Sponsor:
Alza Corporation, DE, USA
Information provided by:
Alza Corporation, DE, USA
ClinicalTrials.gov Identifier:
NCT00410943
First received: December 12, 2006
Last updated: April 26, 2010
Last verified: April 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | June 1999 |
| Estimated Primary Completion Date: | No date given |